Market access & reimbursement

  • Analyze relevant clinical data, expected by HTA bodies.
  • Elaborate strategic recommendations.
    •Secure market access based on expertise and relationships.
  • Define value proposition for innovative technologies and optimize landscape of assessments.
  • Manage reimbursement dossiers, realize critical review of HTA evaluations, set up action plan with key stakeholders.

Pricing strategies & outcomes

  • Analyze pricing and coding on French healthcare database (PMSI).
  • Define pricing strategy and operational actions from the payers
  • Conduct pricing readiness workshops.
  • Elaborate budget impact models (BIM).
  • Negotiate reimbursement tariff with payers.

Public affairs & stakeholder management

  • Carry out stakeholder mappings.
  • Maintain our network of experts and key opinion leaders from varied therapeutic areas
  • Collaborate actively with key players and decision makers.
  • Organise key opinion leader interviews and advisory board.
  • Prepare HTA appeal for health technoligies.

Regulatory support

  • Organise regulatory communications for market access.
  • Secure National funding programs: authorization of submission for clinical trial.
  • Interract with qualified institutions : National Agency for Medicines and Health Products Safety (ANSM), People protection Authority (CPP), Data Protection Authority (CNIL)
  • Offer Regulatory intelligence / Customized newsletter.

Training courses

SGE Consulting offers training in academic and professional fields on market access and reimbursement for innovative health technologies (Université Paris-Saclay, IPIL in Lyon, ISIFC in Franche Comté…).

→ More information, contact us